openPR Logo
Press release

Research of Inclusion Body Myositis in Global Industry : Overview, Size, Share and Trends 2016-2020

01-10-2017 03:06 PM CET | Health & Medicine

Press release from: Inclusion Body Myositis

Albany, NY, 10 JAN : Inclusion body myositis (IBM) is an age related muscle disorder, which is most common among aged individuals and it may lead to severe disability due to its incurable nature. This muscle disorder is mainly characterized by inflammatory myopathy that slowly progresses and causes weakness of the limbs, least or no reflexes from deep tendons, mixing of neurogenic and myopathic changes in electromyography as well as dysphasia. Many a times, IBM remains under-diagnosed as it occurs mainly in the aged individuals, with several co-morbidities, and hence, often misdiagnosed with polymyositis. People over 50 years of age suffering from polymyositis mostly suffer from inclusion body myositis.

Major structural features of IBM include cytoplasmic vacuolation, inflammatory infiltrate and tubo-filamentous inclusions within the nuclei and cytoplasm of the muscle cells. For proper and effective management of IBM, adoption of appropriate diagnostic and therapeutic procedure is essential. Some routine tests can also be adopted for early detection of IBM, such as, tests for full blood count (FBC), calcium and phosphate, creatine kinase, erythrocyte sedimentation rate (ESR), and fasting glucose among others. Some of the specific tests include, nerve conduction tests, electromyography, muscle biopsy (for beta-amyloid and ubiquitin) and electron microscopy. However, there is no therapeutic procedure that has been proved effective in curing IBM. Several therapies are in different stages of clinical trials by different manufacturers worldwide.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=220216

Some of the major driving factors for the growth of IBM market, include, high prevalence of the disorder, growing geriatric population, rising demand for advance therapeutics for specific and effective treatment of IBM and increasing number of drugs for IBM treatment in the pipeline. IBM is the most prevalent muscle disorder that mainly affects people over 50 years of age, but people may suffer from this disorder between 20 to 80 years of their ages. According to the estimates of patient.co.uk, it was found that a population of 10.7 individuals per million in the U.S. are suffering from this disorder. The disease prevalence was least in the Netherlands in Europe with a population of 4.9 individuals per million. It was also found that people over 50 years of age in the least disease prevalent nations like Netherlands and Sweden have shown a prevalence of 16 individuals per million.

Also, men are more prone to IBM with 4:1 to 3:1 ratio compared to the female population. Thus, high prevalence along with high geriatric population will contribute towards the growth of this market. Rising demand for advanced therapeutics and increasing number of drugs in the pipeline will contribute towards the growth of this market in future.

Enquiry @ http://www.researchmoz.us/enquiry.php?type=E&repid=220216

Geographically, North America and Europe are expected to dominate the global inclusion body myositis market in future. Some of the key factors responsible for their dominance in this market can be the presence of high geriatric population along with high demand for advanced therapeutics for effective treatment of this disorder in these regions. However, emerging economies, such as, China, India, Russia, Brazil, South Africa, Turkey, Indonesia, Mexico and others from Asia-Pacific, Middle East, LATAM and African regions will experience rapid growth in future. Some of the key factors responsible for their growth in this market in future are high economic growth, increasing healthcare awareness, developing healthcare infrastructure and rising affordability of the people in these regions. Some of the key players having their drugs in different phases of clinical trials in this market are Gradalis, Inc., New Zealand Pharmaceuticals Ltd., Nobelpharma Co., Ltd., and Novartis AG.

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research of Inclusion Body Myositis in Global Industry : Overview, Size, Share and Trends 2016-2020 here

News-ID: 409409 • Views:

More Releases for IBM

Cloud Microservices Market to Remain Competitive | Major Giants: AWS, CA Technol …
Advance Market Analytics released the research report of Global Cloud Microservices Market, offers a detailed overview of the factors influencing the global business scope. Global Cloud Microservices Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Global Cloud Microservices. This Report covers the emerging player's data,
Global IBM Bluemix Services Market|ibm bluemix service status, ibm bluemix devop …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “IBM Bluemix Services Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Request for Sample Copy click here @ https://www.mrrse.com/sample/16385 The “IBM Bluemix Services Market – Global
Global Government Cloud Market 2018 Analysis by Players - Microsoft, IBM, Google …
Gen Market Insights published latest research on Global Government Cloud Market Research Report 2018 study major consideration after performing various different reasonable and immense analysis on Government Cloud industry. Top to bottom examination of Government Cloud Market is a vital thing for different partners like financial specialists, merchants, providers, CEOs, and others. Government Cloud Market Research Report 2018 provides an rare tool for analyzing the market in terms of strengths and
Global Government Cloud Market 2018 - IBM, Google, IBM, Oracle
Apex market reports, recently published a detailed market research study focused on the Government Cloud Market across the global, regional and country level. The report provides 360° analysis of Government Cloud Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Government Cloud industry, and estimates the future trend of Government Cloud market
Digital Defense, Inc. Receives IBM PartnerWorld’s Ready for IBM Security Intel …
SAN ANTONIO, TX (April 17, 2017) – Digital Defense, Inc., a leading provider of Vulnerability Management as a Service (VMaaS™), today announced it has received IBM PartnerWorld’s Ready for IBM Security Intelligence designation for its Frontline™ Vulnerability Manager. As a result, Digital Defense’s Frontline Vulnerability Manager has been validated to integrate with IBM Security products to help better protect customers around the world. "We're very excited to combine IBM's industry
direct/ datango validated by IBM as Ready for IBM WebSphere Portal Software
datango´s Electronic Performance Support System provides benefits for IBM WebSphere Portal implementations Berlin, October 24, 2007 - datango AG, provider of eLearning and Electronic Per¬formance Support (EPSS) solutions, has been validated for IBM WebSphere Portal software and has earned the "Ready for IBM WebSphere Portal Software" emblem for its datango knowledge suite (dks). The Ready for WebSphere Portal Software emblem means that IBM WebSphere customers and business partners can integrate to